Anonymous21 days ago
NVIDIA CEO Jensen Huang is making a sweeping claim that AI will transform biology from a field of sporadic discovery into a systematic engineering discipline — a vision backed by billions in investment, partnerships with pharma giants like Eli Lilly, and breakthroughs like the Evo 2 genome model. While early clinical data from AI-native biotechs shows promising improvements over traditional drug discovery, critics caution that biology's fundamental complexity may resist the kind of deterministic engineering Huang envisions.